Farshad Ostadian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Farshad Ostadian has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Fereydoun Farrahi
2 shared publicationsArash Alivand
Department of Ophthalmology, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
1 shared publicationAtefeh Mahdian Rad
1 shared publicationElham Farhadi
Clinical Research Development Unit, Golestan Hospital, Ahvaz Jondishapur University of Medical Sciences, Ahvaz
1 shared publication- Gholamreza Khataminia
Department of Ophthalmology, Ophthalmology Research Center, Jundishapur University of Medical Sciences, Ahvaz, Iran
1 shared publication Hani Saber Moghadam
Department of Ophthalmology, Infectious Ophthalmologic Research Center, Ahvaz Jondishapur University of Medical Sciences, Ahvaz
1 shared publication
Latest Publications
- Open Access
- 20 July 2026
- Published by Knowledge E DMCC in Journal of Ophthalmic and Vision Research
- Vol. 21, 1-8
Factors Affecting Visual Outcome After Traumatic Cataract Surgery in a Tertiary Hospital in Ahvaz, Iran
Purpose: Ocular trauma represents a considerable etiological factor for unilateral blindness, especially in developing countries. This research was conducted to examine the determinants influencing visual acuity after surgical intervention for traumatic cataracts. Methods: This retrospective study investigated individuals diagnosed with traumatic cataract who were referred and subsequently underwent surgical intervention in a tertiary hospital in Ahvaz, Iran, from June 2013 to October 2023. All patients were contacted, and a thorough ophthalmological evaluation was performed for each person. Visual acuity was assessed utilizing a range of techniques, including central, steady, maintained (CSM) fixation, LEA symbols, Teller acuity cards, and the Snellen chart. Data were analyzed using SPSS version 25.0, and a P-value <0.05 was considered statistically significant. Results: A total of 64 eyes from 64 patients were included. The mean age was 25.5 ± 22.0 years, and 71.9% were male. Open globe injuries accounted for 75% of cases, most (38%) of which were caused by sharp metal objects. Seventeen patients (26.6%) were under 7 years of age. Significant factors associated with final visual acuity included age (P = 0.021), injury type (P = 0.025), vitreous prolapse (P = 0.012), and size of rupture (r = 0.327, P = 0.024). Younger patients and those without vitreous prolapse had better visual outcomes. Conclusion: Age, injury type, vitreous involvement, and wound size were the main predictors of final visual acuity after traumatic cataract surgery. Comprehensive evaluation and timely surgical management may improve visual prognosis.
- 20 July 2026
- Published by Knowledge E DMCC in Journal of Ophthalmic and Vision Research
- Vol. 21, 1-8
Open AccessFactors Affecting Visual Outcome After Traumatic Cataract Surgery in a Tertiary Hospital in Ahvaz, Iran
Purpose: Ocular trauma represents a considerable etiological factor for unilateral blindness, especially in developing countries. This research was conducted to examine the determinants influencing visual acuity after surgical intervention for traumatic cataracts. Methods: This retrospective study investigated individuals diagnosed with traumatic cataract who were referred and subsequently underwent surgical intervention in a tertiary hospital in Ahvaz, Iran, from June 2013 to October 2023. All patients were contacted, and a thorough ophthalmological evaluation was performed for each person. Visual acuity was assessed utilizing a range of techniques, including central, steady, maintained (CSM) fixation, LEA symbols, Teller acuity cards, and the Snellen chart. Data were analyzed using SPSS version 25.0, and a P-value <0.05 was considered statistically significant. Results: A total of 64 eyes from 64 patients were included. The mean age was 25.5 ± 22.0 years, and 71.9% were male. Open globe injuries accounted for 75% of cases, most (38%) of which were caused by sharp metal objects. Seventeen patients (26.6%) were under 7 years of age. Significant factors associated with final visual acuity included age (P = 0.021), injury type (P = 0.025), vitreous prolapse (P = 0.012), and size of rupture (r = 0.327, P = 0.024). Younger patients and those without vitreous prolapse had better visual outcomes. Conclusion: Age, injury type, vitreous involvement, and wound size were the main predictors of final visual acuity after traumatic cataract surgery. Comprehensive evaluation and timely surgical management may improve visual prognosis.
- Open Access
- 1 January 2013
- Vol. 2 (4) , 109-112
Acetazolamide and Thyroid-Associated Ophthalmopathy; a Preliminary Tested Hypothesis in a TertiaryReferral Center
This study evaluated the effect of acetazolamide on thyroid-associated ophthalmopathy (TAO). Patients with a VISA classification index equal to or more than four were enrolled in the study and were randomly assigned into two groups. In both groups, treatment was initiated using prednisolone. Patients in the case group received acetazolamide tablets 250 mg daily in addition to prednisolone. Three months later, the VISA inflammatory score of patients in both groups were determined. Subsequent to intervention with acetazolamide, the VISA inflammatory score of patients in the case group were reduced as follows; orbital pain (57.1% versus 41.7%, P=0.736), eyelid edema (42.8% versus 27.1%, P=0.67), chemosis (53.3% versus 33%, P=0.31), injection of the eyelids (60% versus 41.6%, P=0.342), and conjunctival injection (50% versus 46.13%, P=0.73). However, these reductions were not statistically significant when compared with those observed in the control group (P=0.246). In conclusion, the effect of acetazolamide on all the parameters of the VISA inflammatory score was examined independently. All patients in the case group revealed a reduction in VISA inflammatory score following intervention. However, these reductions were not statistically significant. Further studies with large sample sizes are required.
- 1 January 2013
- Vol. 2 (4) , 109-112
Open AccessAcetazolamide and Thyroid-Associated Ophthalmopathy; a Preliminary Tested Hypothesis in a TertiaryReferral Center
This study evaluated the effect of acetazolamide on thyroid-associated ophthalmopathy (TAO). Patients with a VISA classification index equal to or more than four were enrolled in the study and were randomly assigned into two groups. In both groups, treatment was initiated using prednisolone. Patients in the case group received acetazolamide tablets 250 mg daily in addition to prednisolone. Three months later, the VISA inflammatory score of patients in both groups were determined. Subsequent to intervention with acetazolamide, the VISA inflammatory score of patients in the case group were reduced as follows; orbital pain (57.1% versus 41.7%, P=0.736), eyelid edema (42.8% versus 27.1%, P=0.67), chemosis (53.3% versus 33%, P=0.31), injection of the eyelids (60% versus 41.6%, P=0.342), and conjunctival injection (50% versus 46.13%, P=0.73). However, these reductions were not statistically significant when compared with those observed in the control group (P=0.246). In conclusion, the effect of acetazolamide on all the parameters of the VISA inflammatory score was examined independently. All patients in the case group revealed a reduction in VISA inflammatory score following intervention. However, these reductions were not statistically significant. Further studies with large sample sizes are required.